|
NICE nixes Novartis asthma med for young kids; Stada sales suffer on European …
FiercePharma NICE has refused to back the use of Novartis' Xolair for young children, saying the asthma drug's cost brings little extra benefits over existing treatments … |
View full post on asthma – Google News